Page last updated: 2024-08-26

terameprocol and masoprocol

terameprocol has been researched along with masoprocol in 34 studies

Research

Studies (34)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (8.82)	18.2507
2000's	13 (38.24)	29.6817
2010's	14 (41.18)	24.3611
2020's	4 (11.76)	2.80

Authors

Authors	Studies
Gezginci, M; Holman, TR; Timmermann, BN; Whitman, S	1
Dorr, RT; Hajicek, N; Kalaitzis, JA; Lambert, JD; Meyers, RO; Pourpak, A	1
Go, ML; Ho, SS	1
Hori, K; Kawakishi, S; Nakayama, T; Osawa, T	1
Giza, P; Gnabre, J; Huang, RC; Hwu, JR; Tseng, WN	1
Chen, H; Gnabre, J; Huang, RC; Hwu, JR; Li, JN; Mold, DE; Park, R; Teng, L; Tseng, WN	1
Heller, JD; Huang, RC; Kast, WM; Kuo, J; Wu, TC	1
Jayaraman, KS	1
Dorr, RT; Lambert, JD; Meyers, RO; Timmermann, BN	1
Chang, CC; Heller, JD; Huang, RC; Kuo, J	1
Ashfaq, R; Bernstein, HS; Brock, M; Deasel, M; Dhara, S; Forastiere, A; Hansel, DE; Harmon, J; Huang, RC; Maitra, A; Montgomery, E; Shimada, Y; Washington, MK	1
Chang, CC; Chung, Y; Henry, RA; Huang, RC; Liang, YC; Lin, E; Mold, DE; Park, R	1
Chang, CC; Huang, RC; Mold, D	1
Blomberg, JA; Goodman, AB; Heller, J; Lopez, RA; Rhodes, M	1
Arnold, S; Dalby, R; Frazer, N; Khanna, N; Stern, J; Tan, M	1
Smolewski, P	1
Church, A; Connor, A; Dalby, R; Frazer, N; Khanna, N; Stern, J	1
Laster, SM; Petty, IT; Pollara, JJ	1
Giacalone, NJ; Lu, B; Sun, Y	1
Aozasa, K; Chng, WJ; Feldman, AL; Huang, G; Kagami, Y; Kwong, YL; Law, M; Ng, SB; Salto-Tellez, M; Selvarajan, V; Shimizu, N; Zhou, J	1
Amin, S; Anderson, KC; Avet-Loiseau, H; Fulciniti, M; Hideshima, T; Li, C; Minvielle, S; Munshi, NC; Nanjappa, P; Prabhala, R; Rodig, S; Tai, YT; Tassone, P	1
Desideri, S; Grossman, SA; Mikkelsen, T; Peereboom, D; Rosenfeld, MR; Supko, JG; Ye, X	1
Borges, KS; Carlotti, CG; Castro-Gamero, AM; de Oliveira, HF; de Paula Gomes Queiroz, R; Fujinami, MM; Moreno, DA; Scrideli, CA; Suazo, VK; Tone, LG	1
Bassett, D; Beaudry, C; Bogenberger, JM; Carpten, J; Frazer, N; Garcia, R; Hagelstrom, RT; Kim, S; Lekakis, L; McDonagh, KT; Mohrland, S; Schroeder, K; Shanmugam, V; Shea, TC; Tibes, R; Von Hoff, D	1
Davies, C; Hall, AG; Hogarth, LA; Lock, RB; Mackenzie, KL	1
Huang, RC; Kimura, K	1
Costa, R; Ducret, T; Ferreira, R; Ferreira-Pinto, MJ; Henriques-Coelho, T; Justino, J; Leite-Moreira, AF; Moreira-Gonçalves, D; Nogueira-Ferreira, R; Quignard, JF; Savineau, JP; Silva, AF; Vitorino, R	1
Dizdar, L; Esposito, I; Knoefel, WT; Krieg, A; Mersch, S; Möhlendick, B; Oesterwind, KA; Raba, K; Riemer, JC; Schütte, SC; Stoecklein, NH; Topp, SA; Verde, PE; Werner, TA	1
Jiménez de Oya, N; Martín-Acebes, MA; Merino-Ramos, T; Saiz, JC	1
Chao, A; Chen, SJ; Lai, CH; Lee, LY; Lee, YS; Lin, CY; Liu, H; Tsai, CL; Wang, TH; Wu, RC; Yang, LY	1
Cui, Q; Du, R; Liu, M; Rong, L	1
Ahluwalia, MS; Anders, NM; Hemingway, A; Romo, CG; Rudek, MA	1
Hur, J; Huy, TXN; Kim, H; Kim, S; Lee, D; Lee, JH; Min, W; Nguyen, TT; Reyes, AWB	1
Chun, JH; Huang, RCC; Jackson, TLB; Kimura, K; Liang, YC; Lin, YL	1

Reviews

3 review(s) available for terameprocol and masoprocol

Article	Year
Survivin-dependent and -independent pathways and the induction of cancer cell death by tetra-O-methyl nordihydroguaiaretic acid. Seminars in oncology, 2006, Volume: 33, Issue:4 Topics: Apoptosis; Cell Division; Humans; Inhibitor of Apoptosis Proteins; Masoprocol; Microtubule-Associated Proteins; Necrosis; Neoplasm Proteins; Neoplasms; Survivin	2006
Terameprocol, a novel site-specific transcription inhibitor with anticancer activity. IDrugs : the investigational drugs journal, 2008, Volume: 11, Issue:3 Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Humans; Masoprocol; Molecular Structure; Transcriptional Activation	2008
Lignans and Their Derivatives from Plants as Antivirals. Molecules (Basel, Switzerland), 2020, Jan-01, Volume: 25, Issue:1 Topics: Antiviral Agents; Benzodioxoles; Biological Products; Biphenyl Compounds; Drug Development; Furans; Lignans; Masoprocol; Plants; Podophyllotoxin	2020

Trials

4 trial(s) available for terameprocol and masoprocol

Article	Year
Phase I/II clinical safety studies of terameprocol vaginal ointment. Gynecologic oncology, 2007, Volume: 107, Issue:3 Topics: Adolescent; Adult; Biomarkers, Tumor; CDC2-CDC28 Kinases; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Masoprocol; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplasm Staging; Ointments; Papillomaviridae; Papillomavirus Infections; Survivin; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	2007
Phase I clinical trial of repeat dose terameprocol vaginal ointment in healthy female volunteers. Sexually transmitted diseases, 2008, Volume: 35, Issue:6 Topics: Administration, Intravaginal; Adult; Animals; Antiviral Agents; Double-Blind Method; Female; Humans; Masoprocol; Ointments; Rabbits; Sexually Transmitted Diseases, Viral; Treatment Outcome; Vagina	2008
Phase I study of terameprocol in patients with recurrent high-grade glioma. Neuro-oncology, 2012, Volume: 14, Issue:4 Topics: Adult; Aged; Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Female; Glioma; Humans; Male; Masoprocol; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome	2012
Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias. Investigational new drugs, 2015, Volume: 33, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; CDC2 Protein Kinase; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukemia; Liver Function Tests; Male; Masoprocol; Maximum Tolerated Dose; Middle Aged; Polyethylene Glycols; Remission Induction	2015

Other Studies

27 other study(ies) available for terameprocol and masoprocol

Article	Year
Structure-activity relationship studies of nordihydroguaiaretic acid inhibitors toward soybean, 12-human, and 15-human lipoxygenase. Journal of medicinal chemistry, 2002, Jun-06, Volume: 45, Issue:12 Topics: Allosteric Site; Enzyme Inhibitors; Glycine max; Humans; Lipoxygenase; Lipoxygenase Inhibitors; Masoprocol; Structure-Activity Relationship	2002
Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid. Bioorganic & medicinal chemistry letters, 2009, Aug-15, Volume: 19, Issue:16 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Masoprocol; Melanoma; Mice; Xenograft Model Antitumor Assays	2009
Restraining the flexibility of the central linker in terameprocol results in constrained analogs with improved growth inhibitory activity. Bioorganic & medicinal chemistry letters, 2013, Nov-15, Volume: 23, Issue:22 Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Masoprocol; Models, Molecular; Molecular Conformation; Molecular Structure; Structure-Activity Relationship; Transcriptional Activation	2013
Suppression of hydrogen peroxide-induced mammalian cytotoxicity by nordihydroguaiaretic acid. Bioscience, biotechnology, and biochemistry, 1992, Volume: 56, Issue:7 Topics: Animals; Biotechnology; Cell Line; Cell Survival; Hydrogen Peroxide; Masoprocol	1992
Antiviral activities of methylated nordihydroguaiaretic acids. 1. Synthesis, structure identification, and inhibition of tat-regulated HIV transactivation. Journal of medicinal chemistry, 1998, Jul-30, Volume: 41, Issue:16 Topics: Alkaline Phosphatase; Animals; Anti-HIV Agents; COS Cells; DNA, Viral; Enzyme Inhibitors; Epithelial Cells; Gene Products, tat; HIV; Humans; Masoprocol; Mice; Plasmids; tat Gene Products, Human Immunodeficiency Virus; Transcriptional Activation	1998
Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. Journal of medicinal chemistry, 1998, Jul-30, Volume: 41, Issue:16 Topics: Acyclovir; Animals; Antiviral Agents; Cell Line, Transformed; Chlorocebus aethiops; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Herpesvirus 1, Human; Herpesvirus 2, Human; Immediate-Early Proteins; Masoprocol; Mutation; Plasmids; Promoter Regions, Genetic; Protein Binding; Simplexvirus; Sp1 Transcription Factor; Transcription, Genetic; Transfection; Vero Cells; Virus Replication	1998
Tetra-O-methyl nordihydroguaiaretic acid induces G2 arrest in mammalian cells and exhibits tumoricidal activity in vivo. Cancer research, 2001, Jul-15, Volume: 61, Issue:14 Topics: Animals; CDC2 Protein Kinase; Cell Division; Cell Line, Transformed; G2 Phase; Masoprocol; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; RNA, Messenger	2001
Johns Hopkins embroiled in fresh misconduct allegations. Nature, 2001, Aug-02, Volume: 412, Issue:6846 Topics: Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Drug Approval; Fatal Outcome; Humans; India; Maryland; Masoprocol; Scientific Misconduct; Universities; Volunteers	2001
tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivo. Cancer letters, 2001, Sep-28, Volume: 171, Issue:1 Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Cycle; Colonic Neoplasms; DNA Replication; Female; Intracellular Membranes; Kidney; Liver; Lung Neoplasms; Male; Masoprocol; Melanoma; Melanoma, Experimental; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, SCID; Mitochondria; Neoplasm Transplantation; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2001
Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression. Proceedings of the National Academy of Sciences of the United States of America, 2004, Sep-07, Volume: 101, Issue:36 Topics: Animals; Apoptosis; Caspase 3; Caspases; CDC2 Protein Kinase; Cell Division; Cell Line; Cell Nucleus; Cyclin B; Cytoplasm; Down-Regulation; Gene Expression Regulation; Inhibitor of Apoptosis Proteins; Masoprocol; Mice; Microtubule-Associated Proteins; Neoplasm Proteins; Survivin	2004
CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target. The American journal of surgical pathology, 2005, Volume: 29, Issue:3 Topics: Adenocarcinoma; Barrett Esophagus; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophagus; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Masoprocol; Precancerous Conditions; RNA, Messenger; RNA, Neoplasm; Tissue Array Analysis	2005
Systemic treatment with tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jun-15, Volume: 11, Issue:12 Topics: Administration, Oral; Animals; Area Under Curve; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Inhibitor of Apoptosis Proteins; Injections, Intravenous; K562 Cells; Masoprocol; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplasms, Experimental; RNA, Messenger; Survivin; Tissue Distribution; Xenograft Model Antitumor Assays	2005
The anticancer activity of the transcription inhibitor terameprocol (meso-tetra-O-methyl nordihydroguaiaretic acid) formulated for systemic administration. Anti-cancer drugs, 2007, Volume: 18, Issue:8 Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Dimethyl Sulfoxide; Excipients; Female; Humans; Infusions, Intravenous; Injections, Intraperitoneal; Masoprocol; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Polyethylene Glycols; Survival Analysis	2007
Inhibition of poxvirus growth by Terameprocol, a methylated derivative of nordihydroguaiaretic acid. Antiviral research, 2010, Volume: 88, Issue:3 Topics: Actins; Antiviral Agents; Bioterrorism; Cell Line; Clinical Trials, Phase I as Topic; Cowpox virus; Humans; Masoprocol; Poxviridae Infections; Vaccinia virus; Virus Attachment; Virus Replication	2010
Terameprocol (tetra-O-methyl nordihydroguaiaretic acid), an inhibitor of Sp1-mediated survivin transcription, induces radiosensitization in non-small cell lung carcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:1 Topics: Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Masoprocol; Radiation-Sensitizing Agents; Sp1 Transcription Factor; Survivin; Tumor Cells, Cultured; Tumor Stem Cell Assay	2011
Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling. The Journal of pathology, 2011, Volume: 223, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apoptosis; Female; Gene Expression Profiling; Gene Regulatory Networks; Genome-Wide Association Study; Humans; Inhibitor of Apoptosis Proteins; Killer Cells, Natural; Lymphoma, Extranodal NK-T-Cell; Male; Masoprocol; Microtubule-Associated Proteins; Middle Aged; Neoplasm Proteins; NF-kappa B; Nose Neoplasms; Oncogenes; Proto-Oncogene Proteins c-myc; Survivin; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Young Adult	2011
Significant biological role of sp1 transactivation in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Oct-15, Volume: 17, Issue:20 Topics: Animals; Apoptosis; Bone Marrow Cells; Cell Cycle; Cell Proliferation; Cell Survival; Gene Knockdown Techniques; Humans; Male; Masoprocol; Melanoma, Experimental; Mice; Mice, SCID; Multiple Myeloma; RNA Interference; Sp1 Transcription Factor; Transcriptional Activation; Tumor Cells, Cultured	2011
Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells. Investigational new drugs, 2013, Volume: 31, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Inhibitor of Apoptosis Proteins; Inhibitory Concentration 50; Male; Masoprocol; Mitotic Index; Radiation-Sensitizing Agents; RNA Splicing; RNA, Messenger; Sp1 Transcription Factor; Survivin; Temozolomide; Transcription, Genetic	2013
p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia. Cell cycle (Georgetown, Tex.), 2015, Volume: 14, Issue:22 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; B-Lymphocytes; Caspase 3; Caspase 7; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Etoposide; Gene Expression Regulation, Leukemic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Masoprocol; Phosphatidylserines; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; RNA, Small Interfering; Signal Transduction; Sp1 Transcription Factor; T-Lymphocytes; Transcription, Genetic; Tumor Suppressor Protein p53; Vorinostat	2015
Tetra-O-Methyl Nordihydroguaiaretic Acid Broadly Suppresses Cancer Metabolism and Synergistically Induces Strong Anticancer Activity in Combination with Etoposide, Rapamycin and UCN-01. PloS one, 2016, Volume: 11, Issue:2 Topics: Antineoplastic Agents; Autophagy; Carbohydrate Metabolism; Caspase 7; Cell Line, Tumor; Down-Regulation; Drug Synergism; Energy Metabolism; Etoposide; Glutathione; Humans; Lipid Metabolism; Male; Masoprocol; Metabolic Networks and Pathways; Metabolome; Neoplasms; Oxidative Stress; Reactive Oxygen Species; Sirolimus; Staurosporine	2016
HMGB1 down-regulation mediates terameprocol vascular anti-proliferative effect in experimental pulmonary hypertension. Journal of cellular physiology, 2017, Volume: 232, Issue:11 Topics: Animals; Antihypertensive Agents; Apoptosis; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Hemodynamics; HMGB1 Protein; Hypertension; Male; Masoprocol; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Protein Interaction Maps; Proteomics; Pulmonary Artery; Rats, Wistar; Recovery of Function; Time Factors; Vascular Remodeling; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling	2017
Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia. Oncotarget, 2017, Jan-31, Volume: 8, Issue:5 Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Carcinoma, Neuroendocrine; Cell Line, Tumor; Cell Proliferation; Comparative Genomic Hybridization; DNA Copy Number Variations; Dose-Response Relationship, Drug; Female; Gene Dosage; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Intestinal Neoplasms; Male; Masoprocol; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Naphthoquinones; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Retrospective Studies; RNA Interference; Signal Transduction; Stomach Neoplasms; Survivin; Time Factors; Transfection; Tumor Burden; X-Linked Inhibitor of Apoptosis Protein; Xenograft Model Antitumor Assays	2017
Antiviral Activity of Nordihydroguaiaretic Acid and Its Derivative Tetra- Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8 Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; HeLa Cells; Humans; Lipid Metabolism; Masoprocol; Pyridines; Pyrrolidines; Sterol Regulatory Element Binding Proteins; Thiazoles; Vero Cells; Virus Replication; West Nile Fever; West Nile virus; Zika Virus; Zika Virus Infection	2017
The combination of everolimus and terameprocol exerts synergistic antiproliferative effects in endometrial cancer: molecular role of insulin-like growth factor binding protein 2. Journal of molecular medicine (Berlin, Germany), 2018, Volume: 96, Issue:11 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Class I Phosphatidylinositol 3-Kinases; Drug Synergism; Endometrial Neoplasms; Everolimus; Female; Humans; Immunosuppressive Agents; Insulin-Like Growth Factor Binding Protein 2; Masoprocol; Mice, Inbred BALB C; Mice, Nude; PTEN Phosphohydrolase	2018
Quantitation of terameprocol in human plasma by liquid chromatography-tandem mass spectrometry. Journal of pharmaceutical and biomedical analysis, 2022, Feb-05, Volume: 209 Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Masoprocol; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry	2022
The In Vitro and In Vivo Effect of Lipoxygenase Pathway Inhibitors Nordihydroguaiaretic Acid and Its Derivative Tetra- Journal of microbiology and biotechnology, 2022, Sep-28, Volume: 32, Issue:9 Topics: Animals; Brucella abortus; Brucellosis; Cytokines; Interleukin-10; Interleukin-12; Leukotriene B4; Lipoxygenase Inhibitors; Lipoxygenases; Masoprocol; Mice; Receptors, Leukotriene B4; Thromboxane A2; Tumor Necrosis Factor-alpha	2022
Tetra-O-methyl-nordihydroguaiaretic acid inhibits energy metabolism and synergistically induces anticancer effects with temozolomide on LN229 glioblastoma tumors implanted in mice while preventing obesity in normal mice that consume high-fat diets. PloS one, 2023, Volume: 18, Issue:5 Topics: Animals; Cell Line, Tumor; Diet, High-Fat; Energy Metabolism; Glioblastoma; Humans; Masoprocol; Mice; NAD; Temozolomide; Tumor Microenvironment	2023